NYSE:TMOLife Sciences
Thermo Fisher Reworks Operations While Targeting Growth In Clinical Data
Thermo Fisher Scientific (NYSE:TMO) plans to close its Franklin, Massachusetts facility, with associated workforce reductions.
The company is also pursuing a significant acquisition of Clario to expand its clinical trial and digital data solutions capabilities.
The Clario transaction is expected to be accretive and is projected to close by mid 2026, subject to customary conditions.
Thermo Fisher Scientific, a major player in life science tools and laboratory equipment, is reshaping parts of...